FPrime Capital Partners
Status
ACTIVE
Global HQ
Massachusetts, United States
Countries of investment
- USA
- United Kingdom
- China
- India
Investment stages
- Seed
- Series A
- Series B
Industries
- Fintech
- AI
- Health Tech
- Data Science
About
F-Prime Capital Partners, previously recognized as Fidelity Biosciences, is a distinguished venture capital firm that draws on the extensive legacy of Fidelity Investments. F-Prime specializes in funding innovative healthcare and technology companies worldwide, empowering visionary entrepreneurs to develop transformative solutions. With a focus on early to growth-stage investments, F-Prime Capital leverages its deep industry expertise and extensive network to drive the success of its portfolio companies and contribute to advancements that improve lives.
F-Prime Capital Partners, previously recognized as Fidelity Biosciences, is a distinguished venture capital firm that draws on the extensive legacy of Fidelity Investments. F-Prime specializes in funding innovative healthcare and technology companies worldwide, empowering visionary entrepreneurs to develop transformative solutions. With a focus on early to growth-stage investments, F-Prime Capital leverages its deep industry expertise and extensive network to drive the success of its portfolio companies and contribute to advancements that improve lives.
Investment Thesis
FPrime Capital is dedicated to investing in groundbreaking companies in healthcare and technology. The firm focuses on therapeutics, medtech, health IT & services, enterprise software, fintech, and frontier tech.
Manager's Experience
Bringing a wealth of experience from the tech and healthcare sectors, the fund manager has actively engaged in over 30 deals, emphasizing early-stage investments with a strategic operator-first approach. With a focus on the North American market, they have successfully navigated diverse investment landscapes, leading to notable exits that showcase a strong data-driven methodology. Their thematic investing style reflects a deep understanding of emerging trends, positioning the portfolio for sustained growth in dynamic industries.
Team
Tom Beck
Tiffany Yu
Steve Knight
Steve Schultz
Stephen Knight
Stacie Weninger
Shervin Ghaemmaghami
Sanjay Aggarwal
Sanjay Aggarwal
Ronit Klein